Punjab

Opportunity to work as a Medical Rep/Area sales executive in Synergy Diagnostics Pvt Ltd. - Freshers may apply

Synergy Diagnostics pvt Ltd, a Bio-pharmaceutical company, with the Largest range of human blood plasma derived bio-pharmaceutical products, used in the prophylaxis & treatment of various life-threatening conditions.We are basically in to Sales & Marketing of imported products Manufactured from Human Blood. Products manufactured are injectable & critical care products.

Opportunity for M. Pharmacy as Senior Research Fellow in Punjabi University

Punjabi University, Patiala, has kept up its spree of winning the highest "A" grade on a four-point scale amongst over 350 universities in the country. The status is awarded by the National Assessment and Accreditation Council (NAAC), which is an autonomous institution of the University Grants Commission, for a period of five years.

Work as PROFESSIONAL SERVICE REPRESENTATIVES, AREA MANAGER in Karnataka Antibiotics & Pharmaceuticals Ltd.

Karnataka Antibiotics & Pharmaceuticals Ltd., (KAPL) Bangalore is a Government Enterprise.  From a modest beginning in 1984, KAPL has grown from strength to strength in the areas of manufacturing and marketing of various life saving and essential drugs. With an ISO accredition from KPMG, Netherlands, KAPL is recognised for its total commitment to quality and services in domestic and international markets. On profit from inception, KAPL facilities are approved by many international clients.

NIPER invites M.Pharm/Ph.D for Professor, Associate Professor, Assistant Professor - 29 posts | All Disciplines

National Institute of Pharmaceutical Education and Research (NIPER) is the first national level institute in pharmaceutical sciences with a proclaimed objective of becoming a centre of excellence for advanced studies and research in pharmaceutical sciences. The Government of India has declared NIPER as an ‘Institute of National Importance’. It is an autonomous body set up under the aegis of Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.

BIOSIMILARS AND ITS REGULATORY CONSIDERATIONS

About Author:
Mahendra N. Suthar
M.S.Pharm. Biotechnology,
National Institute of Pharmaceutical Education and Research,
Mohali, Punjab-160062.
mahendramevada8@gmail.com

Abstracts:
Biosimilars are protein product that are similar to branded biologics and approved by regulatory agencies.  Biosimilars are cost effective and relatively cheaper than branded biologics. In pharmaceutical industry Biosimilars segments became one of the larger and lucrative one. The global Biosimilar segment has attended higher growth rate among them the USA and Europe are leading one. Further it very good opportunity for Pharmergings like India, China, Russia, Brazil etc. Specially India can replicate its well developed genetic segments and can attend higher growth in it. But, certain issues including immunogenicity, marketing competition and regulatory hurdles are needed to be addressed to propel further innovation in this segment. In present review various marketing opportunities, key issues and regulatory consideration for Biosimilars is described in detail.

Walk in for Senior Project Fellows, Programmer in IMT

The Institute of Microbial Technology, a constituent establishment of the Council of Scientific and Industrial Research, Government of India, wishes to recruit  Senior Project Fellows and  Programmer on temporary basis to work in “Gates Foundation Project”  as per details given below.  Accordingly, a Panel of suitable candidates will be made, which will be operative for a maximum period of one year from the date of interview:

LYOPHILIZATION PROCESS - AN OVERVIEW

ABOUT AUTHORS:
*Naveen Kamboj1, Sadanand Maurya2, Sonia Kamboj3, Gaurav kumar Singh2
1Chandigarh College of Pharmacy, Landran, Mohali, Panjab
2Transalam Institute of Pharmaceutical Education and Reaserch, Meerut, Uttar Pradesh
3ISF college of pharmacy moga, Punjab
*kamboj.naveen21@gmail.com

ABSTRACT
The most important method for developing the very stable and suitable formulation for thermolabile as well as thermostable drug is lyophilization which works on the principle of sublimation of ice crystal from frozen material. Principle of the process through the basis of formulation, freezing, primary drying and secondary drying . In order to design optimum lyophilization process, process development scientific need to the critical properties of the formulation and how to apply to this information to process design. Lyophilized formulation not only has the advantage of better stability, but also provide easy handling i.e. shipping and storage. This article present an overview of lyophilization process, its advantage and pharmaceutical application.

INTELLECTUAL PROPERTY AS AN EFFECTIVE TOOL FOR PHARMACEUTICAL COMPETITIVE INTELLIGENCE

About Author:
Mahendra N. Suthar
M.S. (pharm.) Biotechnology
National institute of pharmaceutical education and research,
Mohali, Punjab-160062.
mahendramevada8@gmail.com

Abstract:
Pharmaceutical industry is a most diverse, R&D oriented, hypercompetitive and knowledge sensitive industry. Competitive intelligence (CI) is a process of ethically and systemic data gathering from operating system to draw important business conclusions. Use of CI for drawing important conclusions regarding present scenario and future forecasting is very important and growth determining practice of pharmaceutical industries. Intellectual property rights (IPR) is an integral part of the industry and IPR related information is freely available in public patent databases. By analyzing patents company can derive important conclusion regarding competitor’s R&D activities, quality of research, collaboration and alliance and can convert this information to knowledge which can play important role in taking future decisions. Present review is fully focused on advent of IPR in getting very good information regarding competitor’s strategies and tactics.


Pages